Who’s Hired? Nichi-Iko Looks To Sandoz For Fresh Leadership

As Ethypharm And Krka Announce UK Appointments And Centrient Names Quality Head

Nichi-Iko has revealed its choice of new leadership, looking to Sandoz Japan for its next president and CEO. Meanwhile, Ethypharm and Krka have made fresh appointments in the UK and Centrient has named a new chief quality officer.

Handshake with executive silhouettes
Multiple firms have announced new appointments in January • Source: Shutterstock

Troubled Japanese firm Nichi-Iko Pharmaceutical has named Sandoz Japan country head Shingo Iwamoto as its choice to become the firm’s next president and CEO, after announcing late last year that chief executive Yuichi Tamura was to resign. (Also see "Nichi-Iko Set To Delist In March As Tamura Steps Down As CEO" - Generics Bulletin, 6 December, 2022.)

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Leadership

More from Generics Bulletin